ArticleJournal of diabetes and metabolic disorders2025

Dose-dependent pancreatitis risk associated with GLP-1 agonists.

Joyce Hanyue Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.